02Mar
17Feb
GelMEDIX Completes $13 Million Seed Financing and Announces First Partnership
— Proceeds to support advancement of lead cell therapy program for Geographic Atrophy and next-generation hydrogel regenerative therapy platform — — Partnership with global pharmaceutical company will leverage GelMEDIX regenerative medicine technology to develop stem cell-derived cell therapies — CAMBRIDGE, Mass., Feb. 17, 2026 /PRNewswire/ -- GelMEDIX, Inc., a biotechnology company developing regenerative therapies to restore vision, announced today the completion of a $13 million seed financing led by Safar Partners, with participation from HTL Biotechnology, Beacon Angels, TiE Boston Angels, Boston Harbor...
26Jan
“When sport teams tell you what tech they use, people stand up and take notice”: Wasabi tells us how it is helping Liverpool FC score big on content for fans everywhere
With sports teams looking to provide a fast and rich experience for fans across the world, having access to their content is a vital need - but with games, training sessions and even commercial appearances on the go round the clock, getting hold of the right content at the right time can be tricky. One of the most iconic names in world football, Liverpool FC has been working with Wasabi to transform its cloud...
26Nov
Akston Initiates Clinical Trial of Once-Weekly GLP-1 Weight-Management Therapy for Cats
BEVERLY, Mass., Nov. 25, 2025 /PRNewswire/ -- Akston, the Biotech Built for Pets, announced today the start of a clinical study at Cornell University College of Veterinary Medicine to evaluate its once-weekly GLP-1 weight-management therapy for cats. The trial will assess the therapy over a roughly three-month period in client-owned domestic cats affected by excess weight. Excess weight is one of the most common health issues in cats today. According to the Association for Pet Obesity Prevention (APOP)1, 61% of U.S. cats...
19Nov
Wasabi Introduces High-Performance Class and Expands into Silicon Valley to Take on AI’s Rising Data Storage Costs
BOSTON--(BUSINESS WIRE)--Wasabi Technologies, the Hot Cloud Storage company, expanded further into artificial intelligence with the unveiling of Wasabi Fire, a high-performance storage class that supports AI workloads, available beginning in early 2026. Wasabi has also opened a new storage region in San Jose, Calif., as part of its relationship with IBM Cloud. The milestones reinforce Wasabi’s push to expand its role in AI infrastructure as demand for scalable, high-performance and cost-efficient cloud...
07Nov
RevBio® Receives First FDA Approval for a “Bone Glue” to Treat Extremity Fractures in a Clinical Trial
LOWELL, Mass.--(BUSINESS WIRE)--RevBio® announced today that TETRANITE, the company’s first of its kind regenerative “bone glue” has been approved for a 20-patient pilot study to measure the biomaterial’s safety and efficacy to treat complex, multi-fragmented wrist fractures including those that involve articular surfaces. Read More>>
31Oct
Elizabeth Banks on Her Tips for Packing Light, the Destination That ‘Blew Her Mind,’ and Her Biggest Airplane Pet Peeve
With Elizabeth Banks
Go-to drink order on a plane? Skyhigh Spritz. Our bubbly is fantastic, but on JetBlue, we also have our sauvignon blanc, our rosé, and our malbec, which is a great red, and they're all delicious. They just make it so easy to have a little cocktail on hand and sort of settle into what hopefully is going to be a really fun trip. Read More>>
31Oct
CytoAgents Receives Fourth Grant From National Institutes of Health to Advance Research on Cytokine Release Syndrome
PITTSBURGH--(BUSINESS WIRE)--CytoAgents, Inc., a clinical-stage biotechnology company developing a safe and effective preventative treatment for cytokine release syndrome (CRS) and the neurotoxicity immune effector cell-associated neurotoxicity syndrome (ICANS), announced today that it has been awarded a $2.25 million National Institutes of Health (NIH) grant, the fourth NIH grant totaling $7.85 million in five years. Read More>>
24Oct
New ScorePlay and Wasabi Technologies partnership gives sports organizations the ultimate platform for smarter, faster fan content
New York City, 10.22.2025 - ScorePlay, the leading AI-powered MAM/DAM designed for sports, and Wasabi Technologies, the hot cloud storage company, today announced a strategic partnership that redefines how sports organizations manage, collaborate on, and distribute their content. “The future of sports media is open, intelligent, and instant. We’re empowering every organization to harness AI and cloud technology to manage their content with our bespoke industry offering. By removing the traditional barriers of cost and technical complexity, Wasabi and ScorePlay are giving...
22Oct
